Summary

Visit our virtual booth and listen to our talk during the Cell & Gene meeting on the Mesa.

Our team

Geraldine Guerin-Peyrou
 Geraldine Guerin-Peyrou 
 Director of Marketing & Communication 
About Geraldine Guerin-Peyrou
Director of Marketing & Communication
Aucune information.
Ashlee Sun
 Ashlee Sun 
 Field Application Specialist - AMERICAS 
About Ashlee Sun
Field Application Specialist - AMERICAS
Aucune information.
Fred Ergonis
 Fred Ergonis 
 Director of Sales - West 
About Fred Ergonis
Director of Sales - West
Aucune information.
Julien Depollier
 Julien Depollier 
 Business Director AMERICAS 
About Julien Depollier
Business Director AMERICAS
Aucune information.

Talk: Supporting viral vector therapies from PD to commercialization

The gene therapy industry is currently witnessing an unprecedented growth rate. Despite the rapid growth of the industry, several limitations remain with regarding the robust manufacture of viral vectors and the ability to efficiently produce increasingly larger volumes of finished product. Transient transfection of suspension cells is the most commonly used production platform for AAV manufacturing. However, this method shows some limitations for commercialization: inadequate transfection protocol, reduced transfection efficiency and lower productivity. To address this concern, we present data on Polyplus-transfection novel transfection reagent FectoVIR®-AAV showing: i) increased AAV titers, ii) improved transfection protocol for large scale bioreactors and iii) reproducibility of viral titers at different production scale.

Presented by Géraldine GUERIN-PEYROU, Director of Marketing & Communication at Polyplus-transfection®
Talk available on demand for the duration of the virtual event.

Our solutions for both protein and virus production

NEW! FectoVIR®-AAV: for Recombinant AAV virus production in suspension cells.

PEIpro® product range for a scalable viral vector production for Gene & Cell therapy.

FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).

General information

Registration link for virtual event: click here
Give your feedback!